Text S1:
Step-by-step instructions for the shaking method for GUV formation Materials and reagents
• Micro tube with cap (e.g. Eppendorf)
• Oil-surfactant mix: HFE-7500 fluorinated oil (e.g. 3 M) with 1.4 wt% perfluoropolyether-polyethylene glycol (PFPE-PEG) block-copolymer fluorosurfactants (e.g. Ran Biotechnologies) and 10.5 mM PFPE-carboxylic acid (Krytox, MW: 7000-7500 g/mol, e.g. DuPont)
• SUV-containing aqueous phase: SUVs composed of e.g. 69 % EggPC, 30 % EggPG, 1 % LissRhod-PE (e.g. Avanti Polar Lipids, for SUV formation protocol see Materials and Methods, main manuscript text), dissolved at a lipid concentration of 1.5 mM in e.g. 10 mM MgCl 2 , 200 mM sucrose, 10 mM Tris and 1 mM EDTA, pH 7.4
• Release buffer: 230 mM glucose, 10 mM Tris and 1 mM EDTA, pH 7.4; potentially components for encapsulation
• Droplet-destabilizing agent: Perfluoro-1-octanol (PFO) destabilizing agent (e.g.
Sigma-Aldrich)
• Vortexer or emulsificator (optional) Note that Krytox concentration, lipid composition and buffer conditions can be adjusted as needed, but optimization of the parameters may be required to achieve the best possible GUV formation. For other tested lipid composition and buffer conditions see Table S1 .
Procedure -Timing: 10 minutes
Note that the volumes are scalable to form 10 µL to hundreds of millilitre of GUVs.
The procedure described here is for the formation of 200 µl GUVs.
1. Pipette 400 µl oil-surfactant mix into the microtube. 
Tips for troubleshooting
If the efficiency of GUV formation is very low, please consider the following points:
• Use SUVs within 48 h after formation.
• After approx. 6 weeks, prepare a fresh oil-surfactant mix.
• Test for Krytox contaminations of your block-copolymer fluorosurfactants, e.g. using the Rhodamine 6G assay as described in Figure S5 .
• Make sure that there is no osmotic mismatch between the encapsulated aqueous phase and the release buffer.
• Screen for optimal Krytox concentrations, lipid compositions and buffer conditions for your system.
• Perform FRAP measurements with the GUVs before the release (in the dropletstabilized state). If the diffusion coefficients are about 5 to 10 times lower than you would expect, it is possible that the SUVs have not fused at the droplet periphery. In this case, adjust the conditions (e.g. the Krytox concentration).
• To increase the yield, leave the dsGUVs at 4
• C over night before the release.
This will increase the yield.
• Increase the contact area between the aqueous release buffer and the droplet emulsion. If the droplets are too close to one another during the release, the GUVs may split or fuse during the process.
• The cover slides for observation of the GUVs should be coated with BSA to prevent the fusion of the GUVs with the glass surface. This is especially important if the release buffer contains Mg 2+ ions and if the GUVs are large.
Text S2, Figure S1 : Choosing an appropriate lipid concentration
Only if a sufficient amount of lipids is encapsulated inside the droplets, the GUVs can be released successfully. Therefore, we calculated the required lipid concentration as a function of GUV diameter. The lipid concentration has to be chosen such that the lipids can form a continuous bilayer at the droplet interface. It is important to consider that the surface-tovolume ratio decreases with increasing diameter. The required lipid concentration c Lip can be calculated as:
where n Lip is the amount of lipid molecules and V Drop the volume of the droplet. The required number of lipid molecules, N Lip can be written as:
where A Drop is the area of the droplet and d its diameter; A Head is the area occupied by a single lipid head group. The volume of the droplet V Drop is:
Therefore, the required lipid concentration is inversely proportional to the droplet diameter and can be calculated as:
With the Avogadro constant N A = 6.022 · 10
1 mol
and assuming a lipid head group occupies an area of A Head = 0.7 nm 2 (according to values published earlier 1 ):
The calculated lipid concentration as a function of GUV diameter is plotted in Figure S1 . To quantify the amount of released GUVs, we counted the number of GUVs in at least three confocal snapshots after the GUVs settled down on the coverslide. Since the GUVs were sealed in an observation chamber with a height of 90 µm, the GUVs that settled on the coverslide were previously dispersed in a volume of 90 µm multiplied by the area of the confocal snapshots. The images below in Figure S4 are representative snapshots for a less efficient release (A) and a highly efficient release (B). By extrapolation, we estimate the number of GUVs per milliliter: 1 · 10 6 GUVs in the first and 2 · 10 7 GUVs in the latter case.
The release rate can be approximated by comparing the number of released GUVs to the number of dsGUVs. To produce 1 mL of released GUVs, we use 500 µL of the aqueous phase for droplet formation. By measuring the mean diameter of the dsGUVs, we extrapolate the total number of droplets (here: 4 · 10 7 ). This number is then divided by the number of released GUVs to estimate for the release rate -2.5 % in the first case, 50 % in the latter. by measuring the absorbance at 500 nm. By comparison to this standard, we determined the Krytox contamination of the commercial PEG-based fluorosurfactant we used for our experiments. We found that the surfactant contained 12.4 µM ± 8.8 µM. Note that if the Krytox contamination lies in the millimolar range, this has to be taken into account when supplementing the surfactant with an appropriate Krytox concentration. The assay was carried out according to a previously published protocol.
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Figure S6 , Table S1 : Variation of lipid composition and buffer con- Table 1 : Successfully tested combinations of buffer conditions and lipid compositions for the GUV production via the shaking method. The colour code indicates the release efficiency (gray: efficient (>15%); blue: medium (5%-15%); purple: less efficient (<5%) release) In all cases, the oil phase contained HFE-7500 fluorinated oil, 1.4 wt% PEG-based fluorosurfactant and 10.5 mM Krytox; 0.5 mol% Atto488-labelled DOPE or 1 mol% of LissRhod-PE was added to the lipid mixture for visualization purposes. Video S1: Video protocol of the shaking method for GUV formation This video gives visual guidance to support first-time users of our shaking-method for the formation of GUVs. It follows the steps described in the manuscript (Figure 1 and Materials and Methods section) and the step-by-step protocol described above.
Video S2: Dye influx experiments
This video shows the dye (fluorescein) influx experiments in the presence and absence of α-hemolysin membrane pores. In the presence of α-hemolysin, the fluorescence intensity inside the GUVs is increasing, while GUVs remain dark in its absence. Note that the experiments were carried out at low α-hemolysin concentrations (10.7 nM heptameric pores) to avoid bursting of the GUVs. Under these conditions, inhomogeneities in the distribution of the α-hemolysin across the GUVs are expected and explain the different rates of the increase in fluorescence inside the GUVs.
Video S3: Osmotic deflation of 'shaken' GUVs
This video shows a GUV produced by the shaking method that was osmotically deflated after formation. 4 Deflation leads to an excess membrane area and hence to budding and lipid tubulation.
